Inhaled insulin: Weighing the pros and cons

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 11, 2015, Pages 834-835

  Derosa, Giuseppe ^a   Maffioli, Pamela ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; RECOMBINANT HUMAN INSULIN; ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; BODY WEIGHT DISORDER; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRY POWDER; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPOATROPHY; LIPOHYPERTROPHY; META ANALYSIS (TOPIC); NOTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SELF MONITORING; SYSTEMATIC REVIEW (TOPIC); WEIGHT GAIN; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; MALE;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE;

EID: 84945496485     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00317-4     Document Type: Note

References (9)

1. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997, 350:1505-1510.
2. Carino GP, Mathiowitz E Oral insulin delivery. Adv Drug Deliv Rev 1999, 35:249-257.
3. Gualandi-Signorini AM, Giorgi G Insulin formulations-a review. Eur Rev Med Pharmacol Sci 2001, 5:73-83.
4. Exubera. (accessed Aug 14, 2015). http://www.drugs.com/exubera.html.
5. Lasagna-Reeves CA, Clos AL, Midoro-Hiriuti T, Goldblum RM, Jackson GR, Kayed R Inhaled insulin forms toxic pulmonary amyloid aggregates. Endocrinology 2010, 151:4717-4724.
6. Barnett AH, Lange P, Dreyer M, Serdarevic-Pehar M Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes. Int J Clin Pract 2007, 61:1614-1625.
7. Pittas AG, Westcott GP, Balk EM Technosphere inhaled insulin for patients with diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015, published online Sept 2. http://dx.doi.org/10.1016/S2213-8587(15)00280-6.
8. Zick R, Petersen B, Richter M, Haug C Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with type 2 diabetes on multiple daily insulin injection therapy. Diabetes Technol Ther 2007, 9:483-492. on behalf of the SAFIR Study Group.
9. Derosa G, Franzetti I, Querci F, Romano D, D'Angelo A, Maffioli P Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes. Diabetes Obes Metab 2015, 17:554-559.